PRESS RELEASES
Archives
December 7, 2017 - Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference
November 27, 2017 - Optinose Reports Third Quarter 2017 Financial Results and Recent Operating Highlights
November 20, 2017 - Optinose to Report Third Quarter 2017 Financial Results and Operational Highlights on November 27, 2017
November 17, 2017 - Optinose to Present at Piper Jaffray Healthcare Conference
November 9, 2017 - Optinose to Present at Jefferies 2017 London Healthcare Conference
October 30, 2017 - Optinose Expands Leadership Team With Key Hires
October 17, 2017 - Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
October 12, 2017 - Optinose Announces Pricing of Initial Public Offering
September 18, 2017 - Optinose Announces FDA approval of XHANCE™ (fluticasone propionate) nasal spray for the treatment of nasal polyps
May 9, 2017 - OptiNose Raises $37 Million in Series D Funding Led by Fidelity